Barclays’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.19M Sell
250,000
-30,000
-11% -$709K ﹤0.01% 1797
2025
Q4
$9.09M Buy
280,000
+30,000
+12% +$1.28M ﹤0.01% 1751
2025
Q3
$14.2M Sell
250,000
-41,600
-14% -$2.13M ﹤0.01% 1422
2025
Q2
$14.5M Buy
291,600
+250,000
+601% +$11.3M ﹤0.01% 1313
2025
Q1
$1.23M Buy
+41,600
New +$1.55M ﹤0.01% 2976

Other funds holding HIMS

Barclays's HIMS Position: Q1 2026 in Review

Barclays reduced its Hims & Hers Health (HIMS) stake by 33% in Q1 2026, selling an estimated $7.42M and leaving 639,372 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1307.

Barclays first reported a position in HIMS in Q1 2022 and has held it in 17 quarters since. The position peaked at $37.4M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Barclays held 639,372 shares of Hims & Hers Health worth $13.3M as of Q1 2026.
  • Barclays sold 314,099 Hims & Hers Health shares in Q1 2026, an estimated $7.42M.
  • Hims & Hers Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1307 holding.
  • Barclays first reported a position in Hims & Hers Health in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Hims & Hers Health position peaked at $37.4M in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.